Literature DB >> 30692201

Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.

Alex Chernyavsky1, Kyle T Amber1,2, Arianna F Agnoletti1,3, Candice Wang4, Sergei A Grando5,6,7.   

Abstract

Pemphigus vulgaris (PV) is a potentially lethal mucocutaneous blistering disease characterized by IgG autoantibodies (AuAbs) binding to epidermal keratinocytes and inducing this devastating disease. Here, we observed that non-desmoglein (Dsg) AuAbs in the sera of patients with Dsg1/3 AuAb-negative acute PV are pathogenic, because IgGs from these individuals induced skin blistering in neonatal mice caused by suprabasal acantholysis. Serum levels of AuAbs to desmocollin 3 (Dsc3), M3 muscarinic acetylcholine receptor (M3AR), and secretory pathway Ca2+/Mn2+-ATPase isoform 1 (SPCA1) correlated with the disease stage of PV. Moreover, AuAb absorption on recombinant Dsc3, M3AR, or SPCA1 both prevented skin blistering in the passive transfer of AuAbs model of PV in BALB/c mice and significantly decreased the extent of acantholysis in a neonatal mouse skin explant model. Although acantholytic activities of each of these immunoaffinity-purified AuAbs could not induce a PV-like phenotype, their mixture produced a synergistic effect manifested by a positive Nikolskiy sign in the skin of neonatal mice. The downstream signaling of all pathogenic non-Dsg AuAbs involved p38 mitogen-activated protein kinase (MAPK)-mediated phosphorylation and elevation of cytochrome c release and caspase 9 activity. Anti-Dsc3 and anti-SPCA1 AuAbs also activated SRC proto-oncogene, nonreceptor tyrosine kinase (SRC). Of note, although a constellation of non-Dsg AuAbs apparently disrupted epidermal integrity, elimination of a single pathogenic AuAb could prevent keratinocyte detachment and blistering. Therefore, anti-Dsg1/3 AuAb-free PV can be a model for elucidating the roles of non-Dsg antigen-specific AuAbs in the physiological regulation of keratinocyte cell-cell adhesion and blister development.
© 2019 Chernyavsky et al.

Entities:  

Keywords:  acantholysis; antibody; antigen; apoptosis; autoimmune disease; cell–cell detachment; immune dysfunction; keratinocyte; non-desmoglein pemphigus antibodies; pemphigus

Mesh:

Substances:

Year:  2019        PMID: 30692201      PMCID: PMC6433052          DOI: 10.1074/jbc.RA118.006743

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.

Authors:  Volker Spindler; Franziska Vielmuth; Enno Schmidt; David S Rubenstein; Jens Waschke
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

2.  Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus.

Authors:  Manimegalai Jeyasekaran Dhanabhakya Lakshmi; Telanseri Jaykar Jaisankar; Medha Rajappa; Devinder Mohan Thappa; Laxmisha Chandrashekar; Dakshinamurthy Divyapriya; Malathi Munisamy; Gunaseelan Revathy
Journal:  J Am Acad Dermatol       Date:  2017-01-11       Impact factor: 11.527

3.  Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease.

Authors:  Z Hu; J M Bonifas; J Beech; G Bench; T Shigihara; H Ogawa; S Ikeda; T Mauro; E H Epstein
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.

Authors:  Vinod K Sharma; H R Y Prasad; Sujay Khandpur; Ashok Kumar
Journal:  Int J Dermatol       Date:  2006-05       Impact factor: 2.736

5.  Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Authors:  V T Nguyen; A Ndoye; L D Shultz; M R Pittelkow; S A Grando
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.

Authors:  Irena Zagorodniuk; Sara Weltfriend; Lily Shtruminger; Eli Sprecher; Olga Kogan; Shimon Pollack; Reuven Bergman
Journal:  Int J Dermatol       Date:  2005-07       Impact factor: 2.736

Review 7.  Cross-talk of intracellular calcium stores in the response to neuronal ischemia and ischemic tolerance.

Authors:  Ján Lehotský; Peter Racay; Martina Pavlíková; Zuzana Tatarková; Peter Urban; Mária Chomová; Mária Kovalská; Peter Kaplán
Journal:  Gen Physiol Biophys       Date:  2009       Impact factor: 1.512

8.  Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells.

Authors:  Yoko Hirata; Kyoji Furuta; Satoshi Miyazaki; Masaaki Suzuki; Kazutoshi Kiuchi
Journal:  Brain Res       Date:  2004-09-24       Impact factor: 3.252

9.  Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus.

Authors:  M Dmochowski; T Hashimoto; D R Garrod; T Nishikawa
Journal:  J Invest Dermatol       Date:  1993-04       Impact factor: 8.551

10.  Are clinical phenotype and autoantibody profile always concordant in pemphigus? A study in a cohort of pemphigus patients.

Authors:  Emanuele Cozzani; Giovanni Di Zenzo; Silvia Riva; Valentina Calabresi; Francesco Sera; Massimo Drosera; Aurora Parodi
Journal:  Eur J Dermatol       Date:  2013 Jan-Feb       Impact factor: 3.328

View more
  15 in total

1.  Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.

Authors:  Elias Walter; Franziska Vielmuth; Marie-Therès Wanuske; Matthias Seifert; Robert Pollmann; Rüdiger Eming; Jens Waschke
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

2.  Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.

Authors:  Roberta Lotti; Claudio Giacinto Atene; Alessandra Marconi; Giulia Di Rocco; L Reggiani Bonetti; Tommaso Zanocco Marani; Carlo Pincelli
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

3.  Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris.

Authors:  Giulia Di Lullo; Valentina Calabresi; Feliciana Mariotti; Giovanna Zambruno; Antonio Lanzavecchia; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

4.  Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry.

Authors:  Po-Yuan Wu; Te-Mao Li; Shu-I Chen; Chao-Jung Chen; Jian-Shiun Chiou; Ming-Kuem Lin; Fuu-Jen Tsai; Yang-Chang Wu; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Yu-Ning Lin; Wen-Miin Liang; Ying-Ju Lin
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

Review 5.  Milestones in Personalized Medicine in Pemphigus and Pemphigoid.

Authors:  Katja Bieber; Khalaf Kridin; Shirin Emtenani; Katharina Boch; Enno Schmidt; Ralf J Ludwig
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

Review 6.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

7.  Identification of novel therapeutic targets for blocking acantholysis in pemphigus.

Authors:  Imke A K Burmester; Sarah Flaswinkel; Clara-Sophie Thies; Anika Kasprick; Mayumi Kamaguchi; Valéria Bumiller-Bini; Shirin Emtenani; Nick Feldmann; Khalaf Kridin; Enno Schmidt; Nina van Beek; Detlef Zillikens; Christoph M Hammers; Jennifer E Hundt; Ralf J Ludwig
Journal:  Br J Pharmacol       Date:  2020-09-21       Impact factor: 8.739

Review 8.  Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein.

Authors:  Ambreen Rehman; Yunying Huang; Hong Wan
Journal:  Life (Basel)       Date:  2021-06-26

9.  Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.

Authors:  Xavier Bosch-Amate; Pilar Iranzo; Marta Ivars; José Manuel Mascaró Galy; Agustín España
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

10.  Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?

Authors:  Anna Zakrzewicz; Celina Würth; Benedikt Beckert; Simon Feldhoff; Katrien Vanderheyden; Stian Foss; Jan Terje Andersen; Hans de Haard; Peter Verheesen; Vladimir Bobkov; Ritva Tikkanen
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.